chr2-135754265-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014607.4(UBXN4):c.321C>A(p.His107Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,611,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014607.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UBXN4 | NM_014607.4 | c.321C>A | p.His107Gln | missense_variant | 4/13 | ENST00000272638.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UBXN4 | ENST00000272638.14 | c.321C>A | p.His107Gln | missense_variant | 4/13 | 1 | NM_014607.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249348Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135312
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1459942Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726408
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74244
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.321C>A (p.H107Q) alteration is located in exon 4 (coding exon 4) of the UBXN4 gene. This alteration results from a C to A substitution at nucleotide position 321, causing the histidine (H) at amino acid position 107 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at